The latest on artificial intelligence transforming medicine

OpenBind’s release could become a benchmark moment for AI drug discovery

OpenBind’s first data and model release is notable not just as another drug-discovery announcement, but as a potential infrastructure play for the field. By opening up both data and model assets, it raises the odds that researchers can actually compare approaches, reproduce results, and build on a shared foundation rather than isolated claims.